2025 SPEAKERS Alissa Kamens Strategic Collaborations Associate Promega Corporation Andres Hernandez de la Peña Principal Scientist Neomorph Bin Liu CEO HB Therapeutics, Inc. Bradlee Heckmann President & Chief Scientific Officer Scientific Co-Founder ASHA therapeutics Dmitri Ivanov Associate Professor Biochemistry & Structural Biology University of Texas Health San Antonio Dong Kim Chief Executive Officer AevisBio Inc. Fan Liu Co-Founder & Chief Technology Officer NeoX Biotech Inc. Felix Hausch Professor Technical University of Darmstadt Feng Wang Sr Principal Scientist Pfizer Jacob Hale Senior Scientist Novartis Jia Liu Principal Scientist PhoreMost Julia Dou Director of Protein Chemistry Degron Therapeutics Markus Queisser Scientific Director GlaxoSmithKline Matthew Hayward VP Drug Discovery Magnet Biomedicine Matthias Brand co-founder, Chief Technology & Scientific Officer Proxygen GmbH Meizhong Jin Senior Director - Oncology Chemistry AstraZeneca Peggy Thompson VP Biology Plexium Inc. Rana Quraishi Quraishi ceo Isoprene Pharmaceuticals Rick Ewing VP Head of Chemistry Rapafusyn Pharmaceuticals Stephane Gesta Vice President - Discovery & Translational Biology BPGBio Inc. TAUSEEF BUTT President & Chief Executive Officer Progenra Yao Wang Chief Medical Officer Kangpu Biopharmaceuticals 2025 EVENT GUIDE REGISTER INTEREST PARTNER